<code id='E0734B87A0'></code><style id='E0734B87A0'></style>
    • <acronym id='E0734B87A0'></acronym>
      <center id='E0734B87A0'><center id='E0734B87A0'><tfoot id='E0734B87A0'></tfoot></center><abbr id='E0734B87A0'><dir id='E0734B87A0'><tfoot id='E0734B87A0'></tfoot><noframes id='E0734B87A0'>

    • <optgroup id='E0734B87A0'><strike id='E0734B87A0'><sup id='E0734B87A0'></sup></strike><code id='E0734B87A0'></code></optgroup>
        1. <b id='E0734B87A0'><label id='E0734B87A0'><select id='E0734B87A0'><dt id='E0734B87A0'><span id='E0734B87A0'></span></dt></select></label></b><u id='E0734B87A0'></u>
          <i id='E0734B87A0'><strike id='E0734B87A0'><tt id='E0734B87A0'><pre id='E0734B87A0'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:74
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Bernie Sanders gets little from pharma CEOs on drug prices
          Bernie Sanders gets little from pharma CEOs on drug prices

          Sen.BernieSanders(I-Vt.)raiseshishandataThursdayhearingonCapitolHillinWashingtontoexaminethecostofpr

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Resistance to opioid

          AdobeAtitssurface,itseemslikeasimpleproblemwithasimplesolution.Acrossthecountry,medicinecabinetsarel